Supplementary Data from Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure S2. Schematic depiction of construction of human MDA-7/IL-24-encoding lentivirus (LV-MDA-7) and engineering of T cells.
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362391311
